Format

Send to

Choose Destination
J Natl Cancer Inst. 2015 Aug 11;107(9). pii: djv217. doi: 10.1093/jnci/djv217. Print 2015 Sep.

RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.

Author information

1
Center for Clinical Epidemiology and Biostatistics (XC, TR, JC), Basser Center for BRCA (SD, TR), Abramson Cancer Center (SD, TR), and Division of Hematology-Oncology, Department of Medicine (SD), University of Pennsylvania School of Medicine, Philadelphia, PA; Clinical Genetics Service, Department of Medicine and Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY (NK).
2
Center for Clinical Epidemiology and Biostatistics (XC, TR, JC), Basser Center for BRCA (SD, TR), Abramson Cancer Center (SD, TR), and Division of Hematology-Oncology, Department of Medicine (SD), University of Pennsylvania School of Medicine, Philadelphia, PA; Clinical Genetics Service, Department of Medicine and Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY (NK). jinboche@mail.med.upenn.edu rebbeck@exchange.upenn.edu.

Comment in

PMID:
26264690
PMCID:
PMC4836813
DOI:
10.1093/jnci/djv217
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center